NASDAQ:AMLX | Key Financial Ratios | Amylyx Pharmaceuticals, Inc.

Complete source-backed ratio history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3012.12-57.49%-63.59%
2026-03-3117.85-51.13%-54.95%
2025-12-3114.27-43.51%-47.41%
2025-09-3013.7-41.15%-44.96%
2025-06-308.72-96.40%-111.75%
2025-03-3112.05-99.63%-108.66%
2024-12-316.67-155.83%-183.14%
2024-09-304.55-103.49%-132.24%
2024-06-304.66-49.94%-63.48%
2024-03-314.48-17.03%-21.91%
2023-12-315.669.52%11.37%
2023-09-309.520.39%0.44%
2023-06-306.67-16.05%-18.85%
2023-03-317.54-36.51%-42.24%
2022-12-318.2-50.68%-58.24%
2022-09-305.27-101.42%-127.76%
2022-06-307.96-68.11%-79.57%
2022-03-319.58-44.18%-50.32%
2021-12-316.03-83.26%58.17%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3114.27-43.51%-47.41%
2024-12-316.67-155.83%-183.14%
2023-12-315.669.52%11.37%
2022-12-318.2-50.68%-58.24%
2021-12-316.03-83.26%58.17%